Materials and Methods
Specific Pathogen Free (SPF) juvenile L. vannamei weighing 5 grams were acquired from Shrimp Improvement Systems (SIS) and were acclimated into 200L tanks containing synthetic seawater. Animals were divided into 3 groups with 3 replicates per group and 10 animals per tank. Shrimp were challenged with a lethal dose of IMNV by intramuscular injection into the third abdominal segment using a previously clarified and diluted tissue homogenate positive for IMNV by PCR. Shrimp were then injected 2 days later with 5 micrograms of dsRNA81, dsRNAeGFP, or an equivalent volume of 2% sterile saline. Mortalities were recorded and dead or moribund animals were removed for further diagnostic testing (Figure 1 ).
Results and Discussion
After 20 days, significant differences (P<.05) were noted between dsRNA81 treated animals and dsRNAeGFP or 2% saline controls using ANOVA followed by Tukey's multiple comparison test using JMP 9 software. No significant differences were evident between animals injected with dsRNAeGFP or the 2% saline control. This demonstrates that specific dsRNA can therapeutically treat IMNV in a sequence dependent manner, and may provide a method to treat disease caused by IMNV. 
